How to Buy Biontech Se Stock
Biontech Se
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases.
Biontech Se stock last closed at $111.66, up 1.46% from the previous day, and has increased 38.73% in one year. It has overperformed other stocks in the Biotechnology industry by 1.09 percentage points. Biontech Se stock is currently +45.9% from its 52-week low of $76.53, and -15.08% from its 52-week high of $131.49.
There are currently 240.39M BNTX shares outstanding. The market value of BNTX is $26.84B. In the last 24 hours, 804,000 BNTX shares were traded.
How to Buy Biontech Se Stock
Wondering how to invest in Biontech Se stock? Here's how.
- Decide where to buy Biontech Se stock: You need to choose a stock brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you decide where to buy Biontech Se stock.
- Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Fund your investment account: Select your payment method and add your information.
- Research Biontech Se stock: The Biontech Se ticker symbol is BNTX. Is Biontech Se stock a good investment? Should you buy shares of BNTX? How do BNTX's underlying business fundamentals look? Do top analysts think Biontech Se is a good buy? Why has BNTX's stock price moved recently? (Hint: Our stock market analysis website can help you figure out if BNTX is a good stock to buy).
- Execute your BNTX trade: Decide if you will purchase BNTX shares at the current market price or use a limit order to buy BNTX shares at a particular price.
- Get the latest news on your investment in BNTX: Create a watchlist to keep tabs on your new investment in Biontech Se shares.
Step 1: Decide where to buy Biontech Se stock
You need a brokerage account in order to access the NASDAQ market and buy BNTX stock.
Our preferred brokerage: eToro
We believe that eToro is the best brokerage. Here's why:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to world markets: From Technology to Real Estate, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro offers a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've picked the right brokerage, it's time to fill out some personal info so you can buy BNTX stock today.
How to Start a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to open your new trading account.
- Submit your data by hitting the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you've finished signing up on a investment app, you can securely and quickly fund your account:
Check out this video walkthrough if you need help transferring money into your brokerage account.
Step 4: Research Biontech Se stock
After you have chosen the best place to buy Biontech Se stock, it's absolutely critical to analyze their stock prior to investing, so you actually understand the risk as well as the opportunity.
Biontech Se shares at a glance
BNTX Fundamentals
WallStreetZen was built to help average investors perform better fundamental analysis.
You can view all of the due diligence checks on BNTX's stock page.
Is BNTX stock overvalued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge BNTX's intrinsic value.
Using relative valuations methods:
- BNTX may be undervalued based on its P/B ratio of 1.25x, relative to Biotechnology industry P/B ratio of 4.53x
You can do more valuation analysis on BNTX's stock here.
BNTX Financial Overview
Positive Health Checks:
- There are more short-term assets than short-term liabilities on the BNTX balance sheet.
- Total BNTX debt is lower than 5 years ago, relative to shareholder equity.
- BNTX has $16.30B in cash and short term investments. This is sufficient to cover its annual cash burn of $1.35B.
- BNTX has a low debt to equity ratio of 0.12.
- There are more short-term assets than long-term liabilities on the BNTX balance sheet.
- BNTX has cash burn of 1349431818. It has sufficient cash and short-term investments to cover this for at least one year.
Negative Health Checks:
- BNTX profit margin has gone down from 4.1% to -27.9% in the past year.
Do analysts think it's a good time to buy BNTX stock
Out of 8 Wall Street analysts who give recommendations on BNTX, the consensus analyst rating on BNTX is a Strong Buy
It's important to keep in mind that analyst ratings are not recommendations, nor are they investment advice.
Most Recent BNTX Analyst Upgrades/Downgrades
Terence Flynn, a top 12% analyst from Morgan Stanley maintains BNTX with a strong buy rating and lowers their BNTX price target from $140.00 to $132.00, on May 6, 2025.
John Newman, a bottom 5% analyst from Canaccord Genuity maintains BNTX with a strong buy rating and maintains their BNTX price target from $171.44 to $171.44, on Mar 11, 2025.
Etzer Darout, a top 15% analyst from BMO Capital maintains BNTX with a buy rating and raises their BNTX price target from $130.00 to $143.00, on Mar 11, 2025.
You can dig deeper into what analysts are forecasting on the Biontech Se stock forecast page.
BNTX Trading Indicators
How is BNTX performing as a company?
Last year, BNTX revenue was $3.12B. Over the past five year, BNTX's revenue has gone up by 89.43% per year. This was faster than the Biotechnology industry average of 42.32%.
Learn more about BNTX's earnings and revenue performance here.
Who is buying/selling BNTX?
In the last year, insiders at BNTX have not bought or sold any shares.
Learn more about who owns BNTX shares here.
Does BNTX stock generate passive income?
No, Biontech Se doesn't provide an income stream by paying out dividends.
BNTX Social Trading Data
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Execute your BNTX trade
There are two main options:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are generally fine. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at an exact price limit, use a limit order.
Click the Open button and your broker will place the order.
If you want additional assistance buying stocks on eToro, click the helpful video below:
Step 6: Get the latest news on your investment in BNTX
Now that you own some BNTX stock, you'll want to keep up with your company.
Add BNTX to a watchlist to track the latest developments regarding your BNTX stock.
BNTX Feed
How to Buy Stock in Biontech Se
To reiterate, here are the 6 steps for buying Biontech Se stock:
- Decide where to buy Biontech Se stock
- Sign up for your brokerage account
- Fund your investment account
- Research Biontech Se stock
- Execute your BNTX trade
- Get the latest news on your investment in BNTX
If you are looking for a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you want to keep tabs on your new investment in Biontech Se, click below.
More Stock Buying Guides You Might Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.